ANGELA WEST: Open Payments
NPI 1417136680 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 28 payments from 12 companies in 2025. Trend: 2023 $177 · 2024 $571 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $172 |
| JAZZ PHARMACEUTICALS INC. | 2 | $65 |
| Boston Scientific Corporation | 1 | $64 |
| Abbott Laboratories | 2 | $59 |
| ABBVIE INC. | 2 | $58 |
| Neurelis, Inc. | 2 | $38 |
| ACADIA Pharmaceuticals Inc | 2 | $35 |
| SK Life Science, Inc. | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Medtronic, Inc. | 1 | $23 |
Products named: Fintepla, EPIDIOLEX, General - DBS, INFINITY, VALTOCO, NUPLAZID, BOTOX, Briviact.
Industry payments across MI — which companies pay providers there.
